Quantity size:
0.2ml
Concentration:
1mg/ml蛋白C抑制因子抗体 Buffer = 0.01M TBS(pH7.4) with 1% BSA, 0.03% Proclin300 and 50% Glycerol.
Background:
Protein C Inhibitor (PCI), a member of the serine protease inhibitor (serpin) superfamily, is abundant in plasma and other body fluids. Protein C Inhibitor inhibits a number of "arginine specific" serine proteases of the coagulation and fibrinolytic systems (including thrombin, trypsin, and activated Protein C), as well as plasma and tissue kallikreins and the sperm protease acrosin. This inhibition is regulated by 蛋白C抑制因子抗体glycosaminoglycans, such as heparin and heparan sulphate, and several polyanions. As well as its roles in the regulation of hemostasis and fertilisation, Protein C Inhibitor is involved in cell inflammation, proliferation, apoptosis, tumour cell migration, invasion, and metastasis. Recent studies have demonstrated an association between Protein C Inhibitor and multiple sclerosis lesions.
蛋白C抑制因子抗体Also known as:
Acrosomal serine protease inhibitor; IPSP; PAI 3; PAI3; PCI; PLANH 3; PLANH3; Plasma serine protease inhibitor; Plasminogen activator inhibitor 3; Plasminogen activator inhibitor III; PROCI; Serpin A5; Serpin peptidase inhibitor clade A (alpha 1 antiproteinase antitrypsin) member 5; Serpin peptidase inhibitor clade A member 5; SerpinA5; IPSP_HUMAN.
Specificity:
●
Rabbit Polyclonal IgG,蛋白C抑制因子抗体 affinity purified by Protein A.
●
Reacts with: Human, Mouse, Rat, Chicken, Dog, Cow, Sheep, .
●
Immunogen: KLH conjugated synthetic peptide derived from human Protein C inhibitor.
●
蛋白C抑制因子抗体Predicted Molecular Weight: 43kDa.
Storage:
Shipped at 4℃, Store at -20℃ (Avoid repeated freeze/thaw cycles).
Application:
WB=1:100-500 ELISA=1:500-1000 IHC-P=1:100-500 IHC-F=1:100-500 IF=1:100-500
Not yet tested in other applications.
Optimal working dilutions must be determined by the end user.
kl352Hu01己糖激酶2(HK2)多克隆抗体Polyclonal Antibody to Hexokinase 2 (HK2)
kl353Hu01Slit同源物3(Slit3)多克隆抗体Polyclonal Antibody to Slit Homolog 3 (Slit3)
kl353Mu01Slit同源物3(Slit3)多克隆抗体Polyclonal Antibody to Slit Homolog 3 (Slit3)
kl353Ra01Slit同源物3(Slit3)多克隆抗体Polyclonal Antibody to Slit Homolog 3 (Slit3)
kl354Hu01Slit同源物1(Slit1)多克隆抗体Polyclonal Antibody to Slit Homolog 1 (Slit1)
kl354Mu01Slit同源物1(Slit1)多克隆抗体Polyclonal Antibody to Slit Homolog 1 (Slit1)
kl354Ra01Slit同源物1(Slit1)多克隆抗体Polyclonal Antibody to Slit Homolog 1 (Slit1)
kl368Mu01Kruppel样因子1(KLF1)多克隆抗体Polyclonal Antibody to Kruppel Like Factor 1, Erythroid (KLF1)
kl372Hu01激肽释放酶12(KLK12)多克隆抗体Polyclonal Antibody to Kallikrein 12 (KLK12)
kl373Hu01激肽释放酶13(KLK13)多克隆抗体Polyclonal Antibody to Kallikrein 13 (KLK13)
kl374Hu01激肽释放酶14(KLK14)多克隆抗体Polyclonal Antibody to Kallikrein 14 (KLK14)
kl380Hu01神经源性丝氨酸蛋白酶抑制剂(NSP)多克隆抗体Polyclonal Antibody to Neuroserpin (NSP)
kl386Hu01乳腺丝抑蛋白(Maspin)多克隆抗体Polyclonal Antibody to Mammary Serine Protease Inhibitor (Maspin)
kl387Mu01白细胞弹性蛋白酶抑制因子(LEI)多克隆抗体Polyclonal Antibody to Leukocyte Elastase Inhibitor (LEI)
kl390Hu01胞浆抗蛋白水解酶3(CAP3)多克隆抗体Polyclonal Antibody to Cytoplasmic Antiproteinase 3 (CAP3)
kl392Hu01激肽释放酶结合蛋白(KAL)多克隆抗体Polyclonal Antibody to Kallistatin (KAL)
kl393Hu01蛋白C抑制因子(PCI)多克隆抗体Polyclonal Antibody to Protein C Inhibitor (PCI)
更多
企业名称
上海康朗生物科技有限公司
企业信息已认证
企业类型
信用代码
310112001510759
成立日期
2015-05-29
注册资本
100
经营范围
从事生物科技技术领域内技术开发、技术咨询、技术服务、技术转让,实验分析仪器、化工产品及原料(除危险化学品、监控化学品、烟花爆竹、民用爆竹物品、易制毒化学品)、仪器仪表、环保设备、酒店用品、皮革制品、床上用品、电子产品的销售。【依法须经批准的项目,经相关部门批准后方可开展经营活动】
上海康朗生物科技有限公司
公司地址
上海市闵行区闵北路88弄1-30号第22栋BV145室
客服电话